Dow Up 1.30% Nasdaq Up 0.37%

Celldex Therapeutics, Inc. (CLDX)

-NasdaqGS
17.02 0.17(1.01%) Oct 30, 4:00PM EDT
Prev Close:16.85
Open:16.73
Bid:14.00 x 100
Ask:17.64 x 600
1y Target Est:32.71
Beta:3.45
Earnings Date:Nov 6 - Nov 10 (Est.)
Day's Range:16.35 - 17.39
52wk Range:10.76 - 33.33
Volume:1,625,773
Avg Vol (3m):1,872,800
Market Cap:1.52B
P/E (ttm):N/A
EPS (ttm):-1.21
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CLDX

Comparison

Symbol% ChgMkt Cap
CLDXUp 1.01%1.52B
DNDN160.09M
LLY71.77B
RHHBY252.63B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):577.62
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.32
Quarterly EPS Est (Sep-14) :-0.33
Mean Recommendation*:1.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celldex Therapeutics, Inc., a biopharmaceutical company, focuses on the development, manufacture, and commercialization of novel therapeutics for human health care primarily in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback